8-K: New Horizon Aircraft Secures $25M in Share and Warrant Offering

New Horizon Aircraft Ltd. announced the pricing of a registered direct offering of shares and pre-funded warrants, raising approximately $25 million to fund its Cavorite X7 prototype development.

Summary

• New Horizon Aircraft Ltd. has entered into definitive agreements with institutional investors for a registered direct offering.
• The offering includes the sale of 5,385,646 Class A ordinary shares and 4,574,514 pre-funded warrants.
• Gross proceeds from the offering are approximately $25 million before deducting fees and expenses.
• The pre-funded warrants have an exercise price of $0.001 per share.
• The net proceeds are intended to fully fund the completion of the Cavorite X7 prototype, advancing it towards testing, certification, and commercial production.
• The offering is expected to close on or about May 27, 2026, subject to customary closing conditions.
• Titan Partners Group LLC is acting as the sole placement agent for the offering.
• The securities were offered pursuant to a shelf registration statement on Form S-3.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, as the company successfully secured significant funding to advance its key prototype, indicating investor confidence despite the inherent dilution.

Positives

• Successful capital raise of approximately $25 million to fund critical prototype development.
• Strong support from existing U.S. institutional shareholders.
• Clear use of proceeds to advance the Cavorite X7 prototype towards testing, certification, and commercial production.
• Validation of the company's next-generation aerospace platform and differentiated technologies.
• The offering was made under an effective shelf registration statement, streamlining the process.

Negatives

• The offering will result in dilution to existing shareholders.
• The company may need to raise additional capital in the future, which may not be available on acceptable terms.
• The company's ability to develop, certify, and manufacture the Cavorite X7 aircraft to meet performance expectations is subject to risk.

Risks

• The risk that the company will need to raise additional capital to execute its business plans, which may not be available on acceptable terms or at all.
• The risk that the closing of the Offering is delayed or not completed at all.
• The risk that the net proceeds from the Offering may be deployed differently than currently anticipated.
• Dilution to existing shareholders from the issuance of new shares and warrants.
• The company's ability to develop, certify, and manufacture an aircraft that meets its performance expectations.
• The successful completion of testing and certification of the Cavorite X7 eVTOL.
• The targeted future production of the Cavorite X7 aircraft.

Future Outlook

The company intends to use the net proceeds to fully fund the completion of its Cavorite X7 prototype and advance the program toward testing, certification, and commercial production. The offering is expected to provide sufficient capital for these immediate objectives.

Management Comments

• "This financing reflects strong continued support from our existing institutional investors and further validates the strategic significance of Horizon Aircrafts next-generation aerospace platform," said Brandon Robinson, CEO of Horizon Aircraft.
• "We are now equipped to fully fund completion of our Cavorite X7 prototype and advance the program toward testing, certification, and commercial production, positioning Horizon Aircraft to advance its differentiated technologies and continue building a leading aerospace organization focused on disciplined execution and long-term value creation."

Industry Context

StockSavvy.ai notes that this capital raise is crucial for advanced aerospace companies like New Horizon Aircraft, which require significant funding for prototype development, testing, and certification. The successful completion of this offering, particularly with existing institutional investors, signals confidence in the company's Cavorite X7 VTOL aircraft and its market potential in the rapidly evolving aerospace sector.

Stakeholder Impact

• Existing shareholders will experience dilution due to the issuance of new shares and warrants.
• Investors in the offering will acquire new shares and pre-funded warrants, gaining equity in the company.
• The placement agent will receive cash fees and warrants as compensation for their services.
• Employees may benefit from the company's advancement towards commercial production, potentially impacting future stock options or employment opportunities.

Next Steps

• Closing of the offering on or about May 27, 2026.
• Utilizing net proceeds to fully fund the completion of the Cavorite X7 prototype.
• Advancing the Cavorite X7 program towards testing, certification, and commercial production.
• Maintaining the effectiveness of the registration statement for the placement agent warrants.

Key Dates

Recommendation

The company has successfully raised capital to advance its core project, which is a positive step. However, the dilution from the offering and the inherent risks in aerospace development (testing, certification, production) warrant a cautious approach. Existing investors should hold, while new investors might consider initiating a position given the funding secured, but with awareness of the risks.

Keywords

New Horizon Aircraft, HOVR, Registered Direct Offering, Pre-funded Warrants, Cavorite X7, VTOL Aircraft, Aerospace, Capital Raise